AME

Ametek
D

AME

Arincen87/100B

Ametek return on equity (ROE)

Ametek's return on equity is 13.95%: net income of 1.63B USD over the last twelve months on shareholders' equity of 11.70B USD.

Today
13.95%
Average, 5 years
14.64%
Low, 5 years
13.84%
High, 5 years
15.90%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 1.63B ÷ 11.70B = 13.95%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

What drives Ametek's return on equity?

Net margin
20.0%
profit on each dollar of sales
Asset turnover
0.46×
sales on each dollar of assets
Equity multiplier
1.51×
assets on each dollar of equity
Return on equity
13.9%
FY2025
  • FY202520.0% × 0.46 × 1.51 = 13.9%
  • FY202419.8% × 0.47 × 1.52 = 14.3%
  • FY202319.9% × 0.44 × 1.72 = 15.0%
  • FY202218.9% × 0.49 × 1.66 = 15.5%
  • FY202117.9% × 0.47 × 1.73 = 14.4%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)Net incomeShareholders' equity
Today13.95%1.63B11.70B
FY202531 Dec 202513.93%1.48B10.63B
FY202431 Dec 202414.25%1.38B9.66B
FY202331 Dec 202315.04%1.31B8.73B
FY202231 Dec 202215.51%1.16B7.48B
FY202131 Dec 202114.41%990.05M6.87B
FY202031 Dec 202014.66%872.44M5.95B
FY201931 Dec 201916.84%861.30M5.12B
FY201831 Dec 201818.34%777.93M4.24B
FY201731 Dec 201716.92%681.47M4.03B
FY201631 Dec 201615.73%512.16M3.26B
FY201531 Dec 201518.15%590.86M3.25B
FY201431 Dec 201418.04%584.46M3.24B
FY201331 Dec 201316.49%517.00M3.14B
FY201231 Dec 201218.11%459.13M2.54B
FY201131 Dec 201118.73%384.46M2.05B
FY201031 Dec 201015.99%283.93M1.78B
FY200931 Dec 200913.13%205.77M1.57B
FY200831 Dec 200819.18%246.95M1.29B
FY200731 Dec 200718.38%228.02M1.24B
FY200631 Dec 200618.82%181.93M966.67M
FY200531 Dec 200517.37%140.64M809.52M
FY200431 Dec 200417.09%112.71M659.58M
FY200331 Dec 200316.60%87.82M529.13M
FY200231 Dec 200219.92%83.70M420.18M
FY200131 Dec 200119.73%66.11M335.06M
FY200031 Dec 200024.40%68.53M280.84M
FY199931 Dec 199928.11%60.77M216.20M
FY199831 Dec 199828.99%50.45M174.00M
FY199731 Dec 199731.70%50.40M159.00M
FY199631 Dec 199639.54%51.20M129.50M
FY199531 Dec 199563.15%55.00M87.10M
FY199431 Dec 199453.28%39.00M73.20M
FY199331 Dec 1993-4.42%-7.30M165.30M
FY199231 Dec 199221.11%44.40M210.30M
FY199131 Dec 199117.97%38.00M211.50M
FY199031 Dec 199018.71%37.30M199.40M
FY198931 Dec 198919.65%38.30M194.90M
FY198831 Dec 198816.86%30.50M180.90M
FY198731 Dec 198716.29%41.20M252.90M
FY198631 Dec 198615.84%36.60M231.10M
FY198531 Dec 198515.89%34.90M219.70M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Dividend yield,Debt to equity,Current ratio,All ratios

Common questions about Ametek's ROE

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.